Showing 1981-1990 of 2050 results for "".
- ReGenTree Initiates ARISE-3 (Phase 3) Trial for Dry Eye Syndromehttps://modernod.com/news/regentree-initiates-arise-3-phase-3-trial-for-dry-eye-syndrome/2476577/ReGenTree, a joint venture company between GtreeBNT and RegeneRx Biopharmaceuticals, announced that it initiated a randomized, double masked, placebo-controlled phase 3 clinical trial (ARISE-3) for dry eye syndrome on May 10. The objective of the ARISE-3 study
- Alcon Launches Advancements to the Centurion Vision System at ASCRShttps://modernod.com/news/alcon-launches-advancements-to-the-centurion-vision-system-at-ascrs/2476556/Alcon introduced new phaco technology that is part of the Centurion Vision System, including the Active Sentry Handpiece and Intrepid Hybrid Tip, at the ASCRS annual meeting. These new products, which are designed to improve safety, consistency and control during cataract surgery,
- The Winning Pitch Challenge Featured at ASCRShttps://modernod.com/news/the-winning-pitch-challenge-featured-at-ascrs/2476539/The Winning Pitch Challenge will feature contestants with innovative ophthalmic ideas presenting to a panel of industry leaders on Sunday, May 5 at the annual American Society of Cataract and Refractive Surgery (ASCRS) conference in San Dieg
- ProtoKinetix AAGP in Phase 3 Retinal Replacement Programhttps://modernod.com/news/protokinetix-aagp-in-phase-3-retinal-replacement-program/2476493/ProtoKinetix updated its stockholders regarding phase 3 of testing using AAGP in retinal cell replacement therapy at the University of British Columbia. The study is now using 2 animal models and a significantly larger number of animals in both control and AAGP treated groups for a longer
- Visioneering Technologies Creates Educational Series for Eye Care Practitionershttps://modernod.com/news/visioneering-technologies-creates-educational-series-for-eye-care-practitioners/2476471/Visioneering Technologies, maker of the NaturalVue Multifocal 1 Day contact lenses, announced the creation of a new educational series for eye care practitioners featuring some of the world’s leading researchers and clinicians, according to a company news release. The first installment of
- Asepticys Files 510k Submission With FDA for TriFlect Disinfection Technologyhttps://modernod.com/news/asepticys-files-510k-submission-with-fda-for-triflect-disinfection-technology/2476450/Asepticys announced the completion of multisite human clinical trials for Asepticys’ novel contact lens care solution containing TriFlect technology. The company has submitted a 510(k) application to the FDA. The clinical trials involved over 320 patients at 12 sites across
- Johnson & Johnson Vision Announces Availability of Acuvue Oasys With Transitions Light Intelligent Technology in the U.S.https://modernod.com/news/johnson-johnson-vision-announces-availability-of-acuvue-oasys-with-transitions-light-intelligent-technology-in-the-u-s/2479584/Johnson & Johnson Vision announced the US availability of Acuvue Oasys with Transitions Light Intelligent Technology. The contact lenses adapt to changing light, helping eyes recover from bright light up to 5 seconds faster, reducing halos and starbursts at night, and delivering more sight w
- Mary Lynch, MD, Receives Innovator Award from the American Glaucoma Societyhttps://modernod.com/news/mary-lynch-md-receives-innovator-award-from-the-american-glaucoma-society/2476419/The American Glaucoma Society has named Emory Eye Center ophthalmologist Mary G. Lynch, MD, as the 2019 recipient of the society’s prestigious Innovator Award. The award is given to one physician each year in recognition of his or her contributions to the field of glaucoma. She is the first woman
- SynergEyes Launches Tangible Hydra-PEG Coating on SynergEyes VS Scleral Lenshttps://modernod.com/news/synergeyes-launches-tangible-hydra-peg-coating-on-synergeyes-vs-scleral-lens/2476394/SynergEyes announced that the SynergEyes VS scleral lens is now available with Tangible Hydra-PEG on Contamac material. The Tangible Hydra-PEG coating is designed to solve the problem of contact lens discomfort and dry eyes by minimizing deposits and lens fogging, increasing lens surface water re
- Lilliana Vazquez to Moderate Vision Expo’s EYE2EYE Series with Commonhttps://modernod.com/news/lilliana-vazquez-to-moderate-vision-expos-eye2eye-series-with-common/2476392/Vision Expo has announced Lilliana Vazquez will moderate its inaugural EYE2EYE series with award-winning artist Common. Ms. Vazquez is a multi-media personality that has acted as a host, influencer, style advisor and producer for the biggest names in entertainment, including working as a contribu